BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 16217885)

  • 1. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
    Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
    Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives.
    Berger P; Sturgeon C; Bidart JM; Paus E; Gerth R; Niang M; Bristow A; Birken S; Stenman UH
    Tumour Biol; 2002; 23(1):1-38. PubMed ID: 11893904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
    Butch AW; Woldemariam GA
    Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotropin in cancer.
    Stenman UH; Alfthan H; Hotakainen K
    Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of human chorionic gonadotropin.
    Stenman UH; Alfthan H
    Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotropin beta-subunit nicking enzymes in pregnancy and cancer patient serum.
    Kardana A; Cole LA
    J Clin Endocrinol Metab; 1994 Sep; 79(3):761-7. PubMed ID: 7521352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin.
    Cowans NJ; Suonpaa M; Kouru H; Wright D; Spencer K
    Clin Chem; 2013 Jun; 59(6):968-75. PubMed ID: 23426428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonassembled human chorionic gonadotropin subunits and alphaalpha-homodimers use fast-track processing in the secretory pathway in contrast to alphabeta-heterodimers.
    Merz WE; Krause JM; Roig J; Singh V; Berger P
    Endocrinology; 2007 Dec; 148(12):5831-41. PubMed ID: 17761764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
    Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
    Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
    Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
    Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
    Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin in pregnancy diagnostics.
    Montagnana M; Trenti T; Aloe R; Cervellin G; Lippi G
    Clin Chim Acta; 2011 Aug; 412(17-18):1515-20. PubMed ID: 21635878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a sialic acid specific lectin-immunoassay for the measurement of human chorionic gonadotrophin glycoforms in serum and its application in normal and Down's syndrome pregnancies.
    Abushoufa RA; Talbot JA; Brownbill K; Rafferty B; Kane JW; Robertson WR
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):499-508. PubMed ID: 10762294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
    Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
    J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.
    Ferraro S; Trevisiol C; Gion M; Panteghini M
    Clin Chem; 2018 Feb; 64(2):270-278. PubMed ID: 29021329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human chorionic gonadotropin in testicular germ cell tumors.
    Lempiäinen A; Sankila A; Hotakainen K; Haglund C; Blomqvist C; Stenman UH
    Urol Oncol; 2014 Jul; 32(5):727-34. PubMed ID: 24502963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.